123 related articles for article (PubMed ID: 11696469)
1. Hormone therapy and in-hospital survival after myocardial infarction in postmenopausal women.
Shlipak MG; Angeja BG; Go AS; Frederick PD; Canto JG; Grady D
Circulation; 2001 Nov; 104(19):2300-4. PubMed ID: 11696469
[TBL] [Abstract][Full Text] [Related]
2. Hormone therapy and the risk of stroke after acute myocardial infarction in postmenopausal women.
Angeja BG; Shlipak MG; Go AS; Johnston SC; Frederick PD; Canto JG; Barron HV; Grady D;
J Am Coll Cardiol; 2001 Nov; 38(5):1297-301. PubMed ID: 11691498
[TBL] [Abstract][Full Text] [Related]
3. Hormone replacement therapy, prothrombotic mutations, and the risk of incident nonfatal myocardial infarction in postmenopausal women.
Psaty BM; Smith NL; Lemaitre RN; Vos HL; Heckbert SR; LaCroix AZ; Rosendaal FR
JAMA; 2001 Feb; 285(7):906-13. PubMed ID: 11180734
[TBL] [Abstract][Full Text] [Related]
4. Postmenopausal hormone use in women with acute coronary syndromes.
Parsons E; Newby LK; Bhapkar MV; Alexander KP; White HD; Shah SH; Bushnell CD; Califf RM;
J Womens Health (Larchmt); 2004 Oct; 13(8):863-71. PubMed ID: 15671702
[TBL] [Abstract][Full Text] [Related]
5. Hormone replacement therapy is associated with a decreased prevalence of peripheral arterial disease in postmenopausal women.
Rockman CB; Maldonado TS; Jacobowitz GR; Adelman MA; Riles TS
Ann Vasc Surg; 2012 Apr; 26(3):411-8. PubMed ID: 22285341
[TBL] [Abstract][Full Text] [Related]
6. Use and discontinuation of hormone replacement therapy in women with myocardial infarction: a nationwide study.
Bretler DM; Hansen PR; Abildstrøm SZ; Jørgensen CH; Sørensen R; Hansen ML; Schramm TK; Løkkegaard E; Torp-Pedersen C; Gislason GH
Br J Clin Pharmacol; 2011 Jan; 71(1):105-15. PubMed ID: 21143506
[TBL] [Abstract][Full Text] [Related]
7. Initiation of hormone replacement therapy after acute myocardial infarction is associated with more cardiac events during follow-up.
Alexander KP; Newby LK; Hellkamp AS; Harrington RA; Peterson ED; Kopecky S; Langer A; O'Gara P; O'Connor CM; Daly RN; Califf RM; Khan S; Fuster V
J Am Coll Cardiol; 2001 Jul; 38(1):1-7. PubMed ID: 11451256
[TBL] [Abstract][Full Text] [Related]
8. Hormone replacement therapy among postmenopausal women presenting with acute myocardial infarction: insights from the GUSTO-III trial.
Tackett AH; Bailey AL; Foody JM; Miller JM; Apperson-Hansen C; Ohman EM; Hochman JS; Karnash SL; Califf RM; Topol EJ; Moliterno DJ
Am Heart J; 2010 Oct; 160(4):678-84. PubMed ID: 20934562
[TBL] [Abstract][Full Text] [Related]
9. Current use of unopposed estrogen and estrogen plus progestin and the risk of acute myocardial infarction among women with diabetes: the Northern California Kaiser Permanente Diabetes Registry, 1995-1998.
Ferrara A; Quesenberry CP; Karter AJ; Njoroge CW; Jacobson AS; Selby JV;
Circulation; 2003 Jan; 107(1):43-8. PubMed ID: 12515741
[TBL] [Abstract][Full Text] [Related]
10. Recency and duration of postmenopausal hormone therapy: effects on bone mineral density and fracture risk in the National Osteoporosis Risk Assessment (NORA) study.
Barrett-Connor E; Wehren LE; Siris ES; Miller P; Chen YT; Abbott TA; Berger ML; Santora AC; Sherwood LM
Menopause; 2003; 10(5):412-9. PubMed ID: 14501602
[TBL] [Abstract][Full Text] [Related]
11. Postmenopausal hormone use and risk of large-bowel cancer.
Newcomb PA; Storer BE
J Natl Cancer Inst; 1995 Jul; 87(14):1067-71. PubMed ID: 7616598
[TBL] [Abstract][Full Text] [Related]
12. Predictors of non-invasive therapy and 28-day-case fatality in elderly compared to younger patients with acute myocardial infarction: an observational study from the MONICA/KORA Myocardial Infarction Registry.
Amann U; Kirchberger I; Heier M; Thilo C; Kuch B; Peters A; Meisinger C
BMC Cardiovasc Disord; 2016 Jul; 16():151. PubMed ID: 27411983
[TBL] [Abstract][Full Text] [Related]
13. Determinants of hormone replacement therapy among postmenopausal women enrolled in the French GAZEL cohort.
Ringa V; Ledésert B; Bréart G
Osteoporos Int; 1994 Jan; 4(1):16-20. PubMed ID: 8148567
[TBL] [Abstract][Full Text] [Related]
14. The effect of prothrombotic blood abnormalities on risk of deep vein thrombosis in users of hormone replacement therapy: a prospective case-control study.
Douketis JD; Julian JA; Crowther MA; Kearon C; Bates SM; Barone M; Piovella F; Middeldorp S; Prandoni P; Johnston M; Costantini L; Ginsberg JS
Clin Appl Thromb Hemost; 2011; 17(6):E106-13. PubMed ID: 21159708
[TBL] [Abstract][Full Text] [Related]
15. Diabetes mellitus and trends in hospital survival after myocardial infarction, 1994 to 2006: data from the national registry of myocardial infarction.
Gore MO; Patel MJ; Kosiborod M; Parsons LS; Khera A; de Lemos JA; Rogers WJ; Peterson ED; Canto JC; McGuire DK;
Circ Cardiovasc Qual Outcomes; 2012 Nov; 5(6):791-7. PubMed ID: 23132330
[TBL] [Abstract][Full Text] [Related]
16. Myocardial infarction risk and hormone replacement: differences between products.
de Vries CS; Bromley SE; Farmer RD
Maturitas; 2006 Feb; 53(3):343-50. PubMed ID: 16040209
[TBL] [Abstract][Full Text] [Related]
17. Estrogen replacement therapy and outcome of coronary balloon angioplasty in postmenopausal women.
Abu-Halawa SA; Thompson K; Kirkeeide RL; Vaughn WK; Rosales O; Fujisi K; Schroth G; Smalling R; Anderson HV
Am J Cardiol; 1998 Aug; 82(4):409-13. PubMed ID: 9723624
[TBL] [Abstract][Full Text] [Related]
18. Duration of estrogen replacement therapy in relation to the risk of incident myocardial infarction in postmenopausal women.
Heckbert SR; Weiss NS; Koepsell TD; Lemaitre RN; Smith NL; Siscovick DS; Lin D; Psaty BM
Arch Intern Med; 1997 Jun; 157(12):1330-6. PubMed ID: 9201007
[TBL] [Abstract][Full Text] [Related]
19. The volume of primary angioplasty procedures and survival after acute myocardial infarction. National Registry of Myocardial Infarction 2 Investigators.
Canto JG; Every NR; Magid DJ; Rogers WJ; Malmgren JA; Frederick PD; French WJ; Tiefenbrunn AJ; Misra VK; Kiefe CI; Barron HV
N Engl J Med; 2000 May; 342(21):1573-80. PubMed ID: 10824077
[TBL] [Abstract][Full Text] [Related]
20. The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal women.
Psaty BM; Heckbert SR; Atkins D; Lemaitre R; Koepsell TD; Wahl PW; Siscovick DS; Wagner EH
Arch Intern Med; 1994 Jun; 154(12):1333-9. PubMed ID: 8002685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
